JPRN-UMIN000019886招募中未知
The comparison of basal insulin therapy with average daily risk range (ADRR). - The comparison of basal insulin therapy with average daily risk range (ADRR).
MACHIDA MUNICIPAL HOSPITA0 个研究点目标入组 100 人开始时间: 2015年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with history of diabetic ketoacidosis, or diabetic coma within 6 months prior to the study entry. 2. Patients with during pregnancy or lactation. 3. severe infection, before operation, severe trauma 4. Patients who received steroid therapy 5. Patients with history of cardiac failure. 6. Patients with renal insufficiency (serum creatinine > 1.5mg/dl (male) , > 1.3mg/dl (female), e-GFR < 50ml/min). 7. Patients with severe liver dysfunction. 8. Patients who are hypersensitive to these medicines 9.Patients judged to be inappropriate by physicians in charge.
研究者
相似试验
招募中
3 期
Investigating the effect of Gliclazide-MR on glycaemic control in type 2 diabetic patientsIRCT20230910059395N1Oroumia University of Medical Sciences90
进行中（未招募）
1 期
Comparison of the impact of biphasic insulin aspart 30(BiAsp30), biphasic insulin aspart 70 (BiAsp 70) and insulin aspart on postprandial glucose and lipid metabolism during two consecutive meals in type 2 diabetics.Diabetes mellitus Typ IIMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusEUCTR2008-008486-35-ATMedizinische Universität Graz, Klinische Abteilung für Endokrinologie und Nuklearmedizin
尚未招募
不适用
Comparison of two different techniques(insulin bolus vs glucose insulin infusion) to control blood glucose levels during surgeryCTRI/2017/12/011037Dr Arun P
进行中（未招募）
1 期
COMPARISON OF A BASAL PLUS ONE INSULIN REGIMEN (INSULIN GLARGINE/INSULIN GLULISINE) WITH A BIPHASIC INSULIN REGIMEN (INSULIN ASPART/INSULIN ASPART PROTAMINE 30/70) IN TYPE 2 DIABETES PATIENTS FOLLOWING BASAL INSULIN OPTIMISATION - LanScapeEUCTR2008-007026-19-GBAventis Pharma Ltd trading as sanofi-aventis780
已完成
不适用
Comparison of morning Basal + 1 rapid insulin therapy (Insulin Glulisine + Insulin glargine 300 U/ml vs. Insulin lispro + Insulin glargine BS) using continuous glucose monitoring (CGM):randomised crossover studyJPRN-UMIN000022094General Inuyamachuo Hospital Department of Diabetes30